The Street’s Key Stock Analysts Research Reports
$ABBV,$ED, $CROX, $DRNA, $HCA, $K, $KOS, $MLY, $SHAK, $SQ, $YNDX
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of the Street’s Key analysts outlook for main issues for Wednesday, as follows:
AbbVie Inc. (NYSE:ABBV) was maintained as Buy at Argus, but the independent research firm lowered its price target to 115 from 130 in the call. The firm continues to expect solid growth from Humira in the US and solid growth from Imbruvica, Venclexta Orilissa and hepatitis C drugs, and it sees long-term benefits from the company’s product pipeline.
Consolidated Edison Inc. (NYSE:ED) was raised to Neutral from Sell with a 73 price target at Goldman Sachs.
Crocs Inc. (NASDAQ:CROX) was reiterated as Buy and the target price was raised to 25 from 21 at Pivotal Research. Crocs has a consensus analyst target price of 19.00.
Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) was raised to Buy from Neutral with a 21 price target at B. Riley.
HCA Healthcare Inc. (NYSE:HCA) was reiterated as Buy and the target price was raised to 155 at Argus, based on a continued outperformance ahead.
Kellogg Co. (NYSE:K) was maintained as Buy but the target price was lowered to 74 from 85 at Argus.
Kosmos Energy Ltd. (NYSE:KOS) analysts raised to Buy from Neutral at Goldman Sachs, but the firm lowered its price target to 9 from 11. The stock was indicated up almost 5% after earnings to 6.60, and its consensus target price was previously 10.31.
Mylan N.V. (NASDAQ:MYL) was raised to Buy from Neutral but the price objective was lowered to 42 from 44 at Merrill Lynch.
Shake Shack Inc. (NYSE:SHAK) was raised to Buy from Neutral with a 60 target price at Longbow Research. Shake Shack has its consensus target price at 53.90.
Square Inc. (NYSE:SQ) was raised to Buy from Neutral and the price target was set at 90 at Citigroup. SQ has a consensus target price of 82.13.
Yandex N.V. (NASDAQ:YNDX) was started as Buy at HSBC. The consensus target price is at 39.96.
Latest posts by Paul Ebeling (see all)
- Gold Technical Analysis: Buy Stops Over 1461.30 May Trigger Move into 1471.00 Fibo Mark - November 14, 2019
- The Street’s Key Stock Analysts Research Reports - November 14, 2019
- Commentary: BRICS Summit, China Hopes to Usher in ‘Golden Decade’ for Cooperation - November 14, 2019